|Year : 2000 | Volume
| Issue : 1 | Page : 34-35
Lichen planus treated with betamethasone oral mini-pulse therapy
Rashmi Mittal, Y Manchanda
Source of Support: None, Conflict of Interest: None
Ten Patients, 6 males and 4 females between 7-60 years of age having lichen planus for I month to 2 years were treated with betamethasone 5mg orally on two consecutive days in a week for 3 months. There was excellent (75-100%) response in 6 (60%) patients and good (50-75%) in 4 (40%) patients. None of the patients had significant side effects of the therapy and there were no treatment failures. Betamethasone on two consecutive days in a week as oral mini pulse therapy may be a safe, effective and a better therapeutic alternative for the treatment of lichen planus.
Keywords: Lichen planus, Oral mini-pulse, Betamethasone
|How to cite this article:|
Mittal R, Manchanda Y. Lichen planus treated with betamethasone oral mini-pulse therapy. Indian J Dermatol Venereol Leprol 2000;66:34-5
|How to cite this URL:|
Mittal R, Manchanda Y. Lichen planus treated with betamethasone oral mini-pulse therapy. Indian J Dermatol Venereol Leprol [serial online] 2000 [cited 2020 Jun 1];66:34-5. Available from: http://www.ijdvl.com/text.asp?2000/66/1/34/4860
| Introduction|| |
Lichen planus is usually a milder disease and corticosteroid is the drug of choice for its treatment. However, when the disease is severe/extensive, corticosteroids in higher doses for a prolonged period may be required to control the disease and if they are used in a daily dosage they are likely to cause severe side effects  Therefore, we evaluated betamethasone 5mg administered orally on two consecutive days in a week as oral mini pulse therapy to treat lichen planus.
| Materials and Methods|| |
Ten patients 6 males and 4 females between 7-60 years (mean age 26 years) who had the disease for 1 month to 2 years were taken up for this study. The diagnosis in each patient was made on the basis of presence of characteristic, itchy, flat topped, violaceous papules and or mucosal lesions in a white lacy pattern. It was confirmed by skin or mucosal biopsy showing features of lichen planus. The patients were thoroughly evaluated to rule out any other cutaneous or systemic disease. Each patient had haemogram, renal and liver function tests, blood sugar, urinalysis, stool for occult blood, chest X-ray and ophthalmological examination done before starting the therapy. Blood pressure and body weight were also recorded. Betamethasone 5mg was administered on two consecutive days in a week orally after breakfast to each patient for a period of 3 months. The patients were clinically evaluated every month to assess the healing of the lesions and improvement in the symptoms. The blood pressure, body weight and estimation of blood sugar were done every month to look for any changes in these parameters, while the other investigations were repeated at the end of 3 months. The response to therapy was considered to be excellent, if there was 75-100% flattening of the lesions and no symptoms; good, if the improvement was 50-75% and poor, if it was less than 50%.
| Results|| |
Out of ten patients, 7 had only skin lesions and 1 had skin as well as mucosal lesions. Two patients had only mucosal lesions. Six (60%) patients, 5 having skin lesions and 1 with skin and mucosal lesions had excellent (75-100%) response while 4(40%) patients, 2 each with only skin and only mucosal lesions had good (50-75%) response to the therapy. None of the patients had poor response or treatment failure. Itching in all the patients had completely subsided in 3 weeks. Two patients had weight gain of 5 kgs each and one developed mild cushingoid features. There were no other side effects of the therapy in any of the patients. Laboratory parameters did not reveal any abnormality.
| Discussion|| |
Corticosteroids (betamethasone) in a dose of 5mg on two consecutive days orally as mini-pulse therapy has been used in corticosteroid responsive diseases like vitiligo and alopecia areata with good results and minimal side effects. , In this study we have used corticosteroids in the same regimen to treat lichen planus. The response was excellent in 6 (60%) patients and good in 4 (40%) patients. There were no significant side effects of the therapy and no treatment failures. Though the number of patients included in this study is too small to draw to any conclusion, it seems to be a better, safer and effective therapeutic modality in this disease. Therefore, it needs to be evaluated in a larger number of patients to establish its effectiveness, safety and superiority over the other existing therapeutic modalities
| References|| |
|1.||Black MM. Lichen planus and lichenoid disorders. In: Champion RH, Burton JL, Ebling FIG, eds. Textbook of Dermatology. 5th edn. Oxford: Blackwell Scientific Publications, 1992: 1689-1690. |
|2.||Gallant C, Kenny P. Oral glucocorticoids and their complications. A review. I Am Acad Dermatol 1986; 14: 161 - 177. |
|3.||Pasricha IS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 1993; 32: 753-757. |
|4.||Pasricha IS, Kumrah L. Alopecia totalis treated with oral minipulse therapy with betamethasone. Indian J Dermatol Venereol Leprol 1996 ; 62:106 -109. |